Applications for the “Young Investigator Fund 2019” are no longer possible. Next call will be in spring 2020.
For further information please note our call for applications in the download area below.
Project Manager, Science
Tel. 030-20 62 29 60
The Schering Stiftung and the Fritz Thyssen Stiftung offer start-up grants to fund promising research ideas by young scientists. Support is provided for projects in the fields of biochemical, neuroscience or immunological basic research with biomedical implications. The program is explicitly aimed at highly motivated young investigators who wish to pursue an independent career and conduct their own research which is different from that of their supervisors.
The Schering Stiftung and the Fritz Thyssen Stiftung make possible research projects of young scientists that cannot be realized with existing funds and resources and for which application for other funding is not possible because of a lack of preliminary research. The start-up grant thus lays the foundations for a subsequent multiannual third-party funding.
The Schering Stiftung and the Fritz Thyssen Stiftung have earmarked a total of EUR 120,000 for this grant program. Applicants can apply for up to EUR 60,000 per project.
The young scientist attempts to solve a long-standing but urgent question with novel methods: Are sarcomas, aggressive cancers of muscle, bone, or joints prevalent in children, driven by malignant stem cells?
The young scientist wants to detect brain-reactive B cells in patients with Multiple Sclerosis and related diseases through usage of novel methodological approaches.
The young scientist aims to understand the mechanisms by which very small specialized compartments inside a cell can be formed and how the cell can coordinate its processes and spaces.
The young scientist aims to identify human-derived naturally occurring peptides that boost anti-viral autophagy and that will be the basis for future development of effective, broadly active anti-viral drugs.
The young scientist prepares a framework for more accurate cell type recognition based on geometric deep learning.
The results of the proposed work is expected to to yield scientific breakthroughs relevant to both physiology and pathophysiology and H2S based pharmacotherapy.
These findings will set the basis for understanding of the hormone signalling mechanisms that regulate pivotal body functions and have been implicated in the pathogenesis of multiple disorders including diabetes mellitus
Unter den Linden 32-34
Telefon: +49 - 30 - 20 62 29 65
Thursday to Monday: 1 pm - 7 pm